crawled 2017-03-21 21:04Z
Fangli Chen
publishing since 2021-05-24
- authorized name
- Fangli Chen
- firm or organization
- Proskauer Rose LLP
- practice areas
- Business and Commercial · Intellectual Property
- jurisdictions
- North America · United States
- professional bio
- Provided by author
- author record id
- LEX-AR-MEJD2044
- library record
- complete body of work
- 18 works (2021–2026)
Not provided: law school · bar admissions
publications — 2 titles
- The Patent Playbook2021–2026 · 13
- Minding Your Business2021–2024 · 5
complete body of work
- Supreme Court Reverses Federal Circuit in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision for “Skinny Labels” and Generic Drug Competition
- Supreme Court Hears Oral Argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: Induced Infringement and “Skinny Labels” at a Crossroads
- Supreme Court Takes Up <em>Hikma v. Amarin</em>: Induced Infringement and Skinny Labels in the Crosshairs
see also
works collectionwww.lexblog.com/lib/authors/MEJD2044/works